Cooperation with past evil and use of cell-lines derived from aborted fetuses Alexander R. Pruss may 25, 2004
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
The production of a number of vaccines involves the use of cell-lines originally derived from fetuses directly aborted in the 1960s and 1970s. Such cell-lines, indeed sometimes the very same ones, are important to on-going research, including at Catholic institutions. The cells currently used are removed by a number of decades and by a significant number of cellular generations from the original cells. Moreover, the original cells extracted from the bodies of the aborted fetuses were transformed to produce the cell lines, since otherwise they would be incapable of the kind of culturing that is required.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library||
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Brooke Ellison & Jaymie Meliker (2011). Assessing the Risk of Ovarian Hyperstimulation Syndrome in Egg Donation: Implications for Human Embryonic Stem Cell Research. American Journal of Bioethics 11 (9):22-30.
Melinda B. Fagan (2011). Social Experiments in Stem Cell Biology. Perspectives on Science 19 (3):235-262.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Mark Greene (2006). To Restore Faith and Trust: Justice and Biological Access to Cellular Therapies. Hastings Center Report 36 (1):57-63.
N. Pfeffer & J. Kent (2006). Consent to the Use of Aborted Fetuses in Stem Cell Research and Therapies. Clinical Ethics 1 (4):216-218.
Søren Holm (2006). Who Should Control the Use of Human Embryonic Stem Cell Lines: A Defence of the Donors' Ability to Control. [REVIEW] Journal of Bioethical Inquiry 3 (1-2):55-68.
John A. Robertson (1999). Ethics and Policy in Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):109-136.
Added to index2009-01-28
Total downloads8 ( #181,987 of 1,139,848 )
Recent downloads (6 months)1 ( #165,020 of 1,139,848 )
How can I increase my downloads?